Cargando…
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
Metabolic-associated fatty liver disease (MAFLD) and its potential impact on the severity of COVID-19 have gained significant attention during the pandemic. This review aimed to explore the genetic determinants associated with MAFLD, previously recognized as non-alcoholic fatty liver disease (NAFLD)...
Autores principales: | Buchynskyi, Mykhailo, Oksenych, Valentyn, Kamyshna, Iryna, Vari, Sandor G., Kamyshnyi, Aleksandr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459448/ https://www.ncbi.nlm.nih.gov/pubmed/37632067 http://dx.doi.org/10.3390/v15081724 |
Ejemplares similares
-
The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
por: Buchynskyi, Mykhailo, et al.
Publicado: (2023) -
Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis
por: Buchynskyi, Mykhailo, et al.
Publicado: (2023) -
Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience
por: Kamyshnyi, Aleksandr, et al.
Publicado: (2023) -
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
por: Petakh, Pavlo, et al.
Publicado: (2023) -
Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword
por: Petakh, Pavlo, et al.
Publicado: (2022)